Global Veterinary Vaccines Market: By Type (Swine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, etc.), By Disease (Swine, Poultry, Livestock, Companion Animal, Aquaculture), By Technology (Live Attenuated) Vaccines), Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, etc.) and by Regions – Global Industry Size, Growth, Trends, Opportunities and Forecasts (2020–2025)
Request a sample report here: https://www.marketstatsville.com/request-sample/veterinary-vaccines-market-to-be-valued-at-usd-12-3-billion-by-2025
The Animal Vaccines Market report covers market dynamics, business models, segment/regional analysis, and an in-depth analysis of their respective market shares and the strategies adopted by the major market players operating in the global market. It includes an in-depth analysis of factors influencing the global market and market statistics showing market share/growth analysis by region and by segment. The report’s research puts into perspective one of the most thorough analyzes of the market, capturing all aspects of the animal vaccines market.
Global Animal Vaccines Market Research Report, 2018-2025 (USD Billion)
An Introduction to the Animal Vaccine Industry
The market size of animal vaccines was valued at USD 8.3 billion in 2019 and will grow at a CAGR of 6.9% over the forecast period 2020-2025. Veterinary vaccines control the spread of infectious diseases and diseases in animals and humans. This is essential because the public depends on animals. Animals are recognized as one of the major sources of food, meat, milk, protein, and other commodities such as hides and wool. The most common veterinary vaccine applications include rabies, foot-and-mouth disease, and equine influenza virus vaccines, which further prevent transmission of infectious agents by mimicking naturally acquired immunity. With a variety of unnamed animal diseases growing rapidly, constant vaccine development is essential. Also, the increase in pet ownership has dramatically accelerated the growth of the market.
Veterinary Vaccine Market Dynamics
Various key factors are driving the growth of the global veterinary vaccines market. This includes increasing the accompanying animal populations, increasing the incidence of zoonotic diseases, and various government initiatives for animal safety and wellness. Also, with the increasing demand for animal-derived foods, the direct involvement of various animal societies in maintaining animal health is expected to further increase the demand for veterinary vaccines worldwide.
In addition, continued growth in technological innovation and growing awareness of animal health in emerging and developing countries is expected to create growth opportunities for manufacturers in the market during the forecast period. The need for vaccines is set to increase at a steady pace as pet ownership increases in developed countries and cattle and poultry numbers in developing countries increase. A surge in R&D investment in anti-proliferation vaccines will boost the development of the industry. For example, in August 2016, Elanco invested two-thirds of its food animal sector budget in vaccine development and reducing antibiotic use. Additionally, the increasing demand for veterinary vaccines has led to the emergence of multiple new vaccines. For example, in February 2017, Ceva launched Cevac IBron, a new vaccine that protects against infectious bronchitis virus (IBV).
You can buy the full report here: https://www.marketstatsville.com/buy-now/veterinary-vaccines-market-to-be-valued-at-usd-12-3-billion-by-2025?opt= 2950
However, the lack of awareness of animal health and the potential adverse effects of veterinary vaccines on human and other animal health may limit the growth of the animal vaccines market. In addition, advances in vaccine products and mass production of veterinary vaccines for hybrid animals are opening up new opportunities in the market for veterinary vaccines. On the other hand, the high cost of storing vaccines is also a restraining factor for the market growth of animal vaccines.
Impact of COVID-19 on Animal Vaccines Market
A comprehensive analysis is carried out on the presence of the animal vaccines industry in different regions and countries, top market shares of companies, growth rate and price analysis. The animal vaccines market will be evaluated for severe disruptions due to COVID-19, recovery measures, innovations, new technologies, and emerging sectors.
Animal Vaccines Market: Report Scope
This report presents a study overview of the veterinary vaccine market based on type, disease, and technology.
Global Animal Vaccine Market by Type
small ruminant vaccine
companion animal vaccine
Global Veterinary Vaccine Market by Disease
Global Animal Vaccine Market by Technology
Live attenuated vaccines
Global Animal Vaccines Market Overview Global Animal Vaccines Market Overview
Animal Vaccines Market: Regional Outlook
From a geographical perspective, the veterinary vaccines market is segmented into North America, Asia Pacific, Europe, South America, Middle East and Africa (MEA). North America achieved the highest revenue in the global animal vaccines market in 2019, followed by Asia Pacific and Europe. The region’s growth is due to increased animal adoption, excessive consumption of meat and milk, and growing awareness of the benefits of using animal vaccines. In addition, Asia-Pacific has high market potential due to increasing pet ownership and increasing incidence of various zoonotic diseases, which may influence the market trend of animal vaccines. . Additionally, ongoing research into innovative vaccine production techniques is increasing due to the high demand for animals and accompanying animal-based food products. Increased investment in animal health companies has also improved the production of innovative vaccines.
The Asia-Pacific market for animal vaccines is expected to grow at the fastest rate in the global market during the forecast period. Key factors driving this market growth include increasing pet adoption, expansion of key vaccine players, increased product availability, and investment in manufacturing facilities in Asia-Pacific countries, particularly India, China, and Thailand. will be
Animal Vaccine Market: Competitive Landscape
Leading veterinary vaccine manufacturers in the global market include Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi SA, and Romvac.
Other veterinary vaccine manufacturers include Vaxxinova, Biovac, Merial and Anicon Labor GmbH, Boehringer Ingelheim, Elanco, Phibro Animal Health Corporation, and Virbac SA.
In 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. (USA). The partnership aimed to introduce Innoject Pro, a newly designed vaccination technology for subcutaneous chicks. The technology it is designed to use in conjunction with Merck Animal Health’s Innovax range of vaccines used in poultry to protect against infectious diseases.
In 2019, Pharmaq (part of Zoetis) signed a partnership agreement with Caritas (USA). The partnership aimed to improve the productivity and sustainability of tilapia fish in the country’s value chain. The partnership will also provide tilapia farmers with training in fisheries health management and aquaculture best practices.
The Animal Vaccines Market report offers an exhaustive analysis of macroeconomic factors and market attractiveness of every segment. The report includes a detailed qualitative and quantitative assessment of the segment/regional outlook along with the presence of market players in their respective segments and regions/countries. The information concluded in the report includes input from industry participants and industry experts across the value chain.
The Animal Vaccines Market Report covers a comprehensive analysis on:
Market size in value and volume
Supply and demand analysis
Supply chain/value chain
Market factor analysis
15+ company profiles
Access full report description, TOC, diagrams, charts and more: https://www.marketstatsville.com/table-of-content/veterinary-vaccines-market-to-be-valued-at-usd-12-3 -billion-by-2025
Regional analysis includes:
North America (USA, Canada, Mexico)
South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, Netherlands, Norway, Sweden, Denmark, rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, Philippines, Singapore, Australia and New Zealand, Rest of Asia Pacific)
Middle East and Africa (Saudi Arabia, UAE, South Africa, North Africa, Rest of MEA)
Animal Vaccine Market: Target Audience
animal vaccine manufacturers
Animal hospitals and clinics
healthcare vaccine manufacturers
trade publications and magazines
Government Agencies, Associations and Organizations